42 results
425
SLRN
Acelyrin, Inc.
21 Feb 25
Business combination disclosure
6:03am
statement and the joint proxy statement/prospectus and other relevant materials to be filed with the SEC regarding the proposed transaction when they become
425
SLRN
Acelyrin, Inc.
7 Feb 25
Business combination disclosure
5:00pm
and the joint proxy statement/prospectus and other relevant materials to be filed with the SEC regarding the proposed merger when they become available
425
SLRN
Acelyrin, Inc.
7 Feb 25
Business combination disclosure
4:07pm
of such participants by reading the registration statement and the joint proxy statement/prospectus and other relevant materials to be filed with the SEC regarding
425
ALMS
Alumis Inc. Common Stock
6 Feb 25
Business combination disclosure
9:40pm
and the joint proxy statement/prospectus and other relevant materials to be filed with the SEC regarding the proposed merger when they become available
425
SLRN
Acelyrin, Inc.
6 Feb 25
Business combination disclosure
9:09pm
the registration statement and the joint proxy statement/prospectus and other relevant materials to be filed with the SEC regarding the proposed
425
b4gby g24
6 Feb 25
Business combination disclosure
8:36pm
425
zrjnd 0mf
6 Feb 25
Business combination disclosure
7:51pm
425
jrw89rjacq8ex
6 Feb 25
Business combination disclosure
7:47pm
425
t6f1 m6m7rb
6 Feb 25
Business combination disclosure
5:22pm
425
mgy7 nthy5
6 Feb 25
Business combination disclosure
5:21pm
425
EX-99.1
y3tlnk90a 3p
6 Feb 25
Business combination disclosure
5:21pm
425
EX-2.1
h9j7mo1w
6 Feb 25
Business combination disclosure
5:21pm
8-K
qpyv wsvoo1
6 Feb 25
Entry into a Material Definitive Agreement
5:19pm
8-K
EX-99.1
878tchq3u1amo
6 Feb 25
Entry into a Material Definitive Agreement
5:19pm
8-K
EX-2.1
5m6kwp69px0f6cy8s
6 Feb 25
Entry into a Material Definitive Agreement
5:19pm
8-K
EX-10.1
107lndvy e9zrtmf
10 Dec 24
ACELYRIN, INC. Announces Topline Results From Phase 2b/3 Study of Izokibep for the Treatment of Uveitis
4:34pm
S-3
EX-4.6
yt6i0
13 Nov 24
Shelf registration
5:26pm
S-3
hxc luw1eqz10f3u
13 Nov 24
Shelf registration
5:26pm